Vagus Nerve Stimulation Market By Product (Implantable VNS devices, External VNS devices), By Application (Epilepsy, Depression, Others), By End user (Hospitals, Neurology clinics, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032
The global vagus nerve stimulation market size was valued at $488.5 million in 2022, and is projected to reach $836.1 million by 2032, growing at a CAGR of 5.5% from 2023 to 2032.
Vagus nerve stimulation (VNS) is a medical treatment that involves the use of electrical impulses to stimulate the vagus nerve, which is a large nerve that runs from the brainstem to the abdomen. The vagus nerve is responsible for regulating many important physiological functions, including heart rate, digestion, and breathing. The implantable device is typically implanted under the skin in the chest or neck, and a wire is attached to the vagus nerve. The electrical impulses generated by this device can help to regulate various physiological functions in the body, including heart rate, breathing, and digestion. VNS therapy is currently used to treat several medical conditions, including epilepsy, depression, and migraine.
VNS is generally considered safe and well-tolerated, although there are some side effects such as hoarseness, coughing, change in voice, and neck pain. These devices are of two types such as implantable VNS devices and externally VNS devices. Vagus nerve stimulation has been FDA-approved treatment for epilepsy and depression. In addition, compared to traditional medications, electrical stimulation of nerves can offer several advantages, such as targeted and adjustable stimulation, reduces risk of systemic side effects, and the potential for long-term benefits.
The global vagus nerve stimulation market is majorly driven by rise in number of people suffering from epilepsy and rise in technological advancements in vagus nerve stimulation devices. For instance, in 2021, Centers for Disease Control and Prevention (CDC), estimated that 5% of adults suffered from depression across the globe. Thus, the increase in prevalence of chronic diseases such as epilepsy, depression, and chronic pain, is driving the demand for VNS devices to manage and treat the disease.
However, high costs associated with vagus nerve stimulator devices and the lack of skilled personnel in some countries hinder market growth to some extent. In addition, many people in underdeveloped nations are not aware of the importance of vagus nerve stimulation therapy and do not understand the potential benefits of these treatments; which can also limit the market growth.
Moreover, development and technological advancements in vagus nerve stimulation devices provide growth opportunities in the emerging economies of Asia-Pacific and LAMEA regions during the forecast period. There have been significant advancements in VNS technology such as the development of minimally invasive devices and closed-loop systems that adjust the stimulation based on patient needs. For instance, Soterix Medical Inc. introduced the first transcutaneous auricular vagus nerve stimulator (taVNS), which provides the necessary pulse parameter settings and offers portable option to modulate the vagus system. These technological advancements have improved the effectiveness and accessibility of VNS therapy which is expected to drive the market growth. Furthermore, surge in awareness among healthcare providers and patients about benefits of VNS therapy, to treat a variety of conditions, is further driving demand for VNS devices.
The global vagus nerve stimulation market is segmented into product, application, end user, and region. By product, the market is categorized into implantable VNS devices and external VNS devices. By application, the market is classified into epilepsy, depression, and others. By end user, the market is classified into hospitals, neurology clinics, and others. Region wise, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Major key players that operate in the global vagus nerve stimulation market are Beijing PINS Medical Co., Ltd, Cirtec, electroCore, Inc., LivaNova PLC, MicroTransponder Inc., tVNS Health GmbH, Parasym Ltd, Neuropix Company Ltd., Soterix Medical Inc., and SetPoint Medical.
Key Benefits For Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the vagus nerve stimulation market analysis from 2022 to 2032 to identify the prevailing vagus nerve stimulation market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the vagus nerve stimulation market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global vagus nerve stimulation market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Product
Implantable VNS devices
External VNS devices
By Application
Epilepsy
Depression
Others
By End user
Hospitals
Neurology clinics
Others
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
South Korea
Rest of Asia-Pacific
LAMEA
Latin America
Middle East And Africa
Key Market Players
Beijing PINS Medical Co., Ltd
electroCore, Inc.
LivaNova PLC
MicroTransponder Inc.
Neuropix Company Ltd.
Parasym Ltd
SetPoint Medical Corporation
Soterix Medical Inc.
tVNS Health GmbH
Please Note: It will take 7-10 business days to complete the report upon order confirmation.
- CHAPTER 1: INTRODUCTION
- 1.1. Report description
- 1.2. Key market segments
- 1.3. Key benefits to the stakeholders
- 1.4. Research Methodology
- 1.4.1. Primary research
- 1.4.2. Secondary research
- 1.4.3. Analyst tools and models
- CHAPTER 2: EXECUTIVE SUMMARY
- 2.1. CXO Perspective
- CHAPTER 3: MARKET OVERVIEW
- 3.1. Market definition and scope
- 3.2. Key findings
- 3.2.1. Top impacting factors
- 3.2.2. Top investment pockets
- 3.3. Porter’s five forces analysis
- 3.3.1. Bargaining power of suppliers
- 3.3.2. Bargaining power of buyers
- 3.3.3. Threat of substitutes
- 3.3.4. Threat of new entrants
- 3.3.5. Intensity of rivalry
- 3.4. Market dynamics
- 3.4.1. Drivers
- 3.4.1.1. Increase in prevalence and incidence of epilepsy
- 3.4.1.2. Rise in demand for minimally invasive devices
- 3.4.1.3. Initiatives by government and non-government organizations
- 3.4.2. Restraints
- 3.4.2.1. High cost of vagus nerve stimulation devices
- 3.4.3. Opportunities
- 3.4.3.1. Rise in technological advancements
- 3.5. COVID-19 Impact Analysis on the market
- CHAPTER 4: VAGUS NERVE STIMULATION MARKET, BY PRODUCT
- 4.1. Overview
- 4.1.1. Market size and forecast
- 4.2. Implantable VNS devices
- 4.2.1. Key market trends, growth factors and opportunities
- 4.2.2. Market size and forecast, by region
- 4.2.3. Market share analysis by country
- 4.3. External VNS devices
- 4.3.1. Key market trends, growth factors and opportunities
- 4.3.2. Market size and forecast, by region
- 4.3.3. Market share analysis by country
- CHAPTER 5: VAGUS NERVE STIMULATION MARKET, BY APPLICATION
- 5.1. Overview
- 5.1.1. Market size and forecast
- 5.2. Epilepsy
- 5.2.1. Key market trends, growth factors and opportunities
- 5.2.2. Market size and forecast, by region
- 5.2.3. Market share analysis by country
- 5.3. Depression
- 5.3.1. Key market trends, growth factors and opportunities
- 5.3.2. Market size and forecast, by region
- 5.3.3. Market share analysis by country
- 5.4. Others
- 5.4.1. Key market trends, growth factors and opportunities
- 5.4.2. Market size and forecast, by region
- 5.4.3. Market share analysis by country
- CHAPTER 6: VAGUS NERVE STIMULATION MARKET, BY END USER
- 6.1. Overview
- 6.1.1. Market size and forecast
- 6.2. Hospitals
- 6.2.1. Key market trends, growth factors and opportunities
- 6.2.2. Market size and forecast, by region
- 6.2.3. Market share analysis by country
- 6.3. Neurology clinics
- 6.3.1. Key market trends, growth factors and opportunities
- 6.3.2. Market size and forecast, by region
- 6.3.3. Market share analysis by country
- 6.4. Others
- 6.4.1. Key market trends, growth factors and opportunities
- 6.4.2. Market size and forecast, by region
- 6.4.3. Market share analysis by country
- CHAPTER 7: VAGUS NERVE STIMULATION MARKET, BY REGION
- 7.1. Overview
- 7.1.1. Market size and forecast By Region
- 7.2. North America
- 7.2.1. Key trends and opportunities
- 7.2.2. Market size and forecast, by Product
- 7.2.3. Market size and forecast, by Application
- 7.2.4. Market size and forecast, by End user
- 7.2.5. Market size and forecast, by country
- 7.2.5.1. U.S.
- 7.2.5.1.1. Key market trends, growth factors and opportunities
- 7.2.5.1.2. Market size and forecast, by Product
- 7.2.5.1.3. Market size and forecast, by Application
- 7.2.5.1.4. Market size and forecast, by End user
- 7.2.5.2. Canada
- 7.2.5.2.1. Key market trends, growth factors and opportunities
- 7.2.5.2.2. Market size and forecast, by Product
- 7.2.5.2.3. Market size and forecast, by Application
- 7.2.5.2.4. Market size and forecast, by End user
- 7.2.5.3. Mexico
- 7.2.5.3.1. Key market trends, growth factors and opportunities
- 7.2.5.3.2. Market size and forecast, by Product
- 7.2.5.3.3. Market size and forecast, by Application
- 7.2.5.3.4. Market size and forecast, by End user
- 7.3. Europe
- 7.3.1. Key trends and opportunities
- 7.3.2. Market size and forecast, by Product
- 7.3.3. Market size and forecast, by Application
- 7.3.4. Market size and forecast, by End user
- 7.3.5. Market size and forecast, by country
- 7.3.5.1. Germany
- 7.3.5.1.1. Key market trends, growth factors and opportunities
- 7.3.5.1.2. Market size and forecast, by Product
- 7.3.5.1.3. Market size and forecast, by Application
- 7.3.5.1.4. Market size and forecast, by End user
- 7.3.5.2. France
- 7.3.5.2.1. Key market trends, growth factors and opportunities
- 7.3.5.2.2. Market size and forecast, by Product
- 7.3.5.2.3. Market size and forecast, by Application
- 7.3.5.2.4. Market size and forecast, by End user
- 7.3.5.3. UK
- 7.3.5.3.1. Key market trends, growth factors and opportunities
- 7.3.5.3.2. Market size and forecast, by Product
- 7.3.5.3.3. Market size and forecast, by Application
- 7.3.5.3.4. Market size and forecast, by End user
- 7.3.5.4. Italy
- 7.3.5.4.1. Key market trends, growth factors and opportunities
- 7.3.5.4.2. Market size and forecast, by Product
- 7.3.5.4.3. Market size and forecast, by Application
- 7.3.5.4.4. Market size and forecast, by End user
- 7.3.5.5. Spain
- 7.3.5.5.1. Key market trends, growth factors and opportunities
- 7.3.5.5.2. Market size and forecast, by Product
- 7.3.5.5.3. Market size and forecast, by Application
- 7.3.5.5.4. Market size and forecast, by End user
- 7.3.5.6. Rest of Europe
- 7.3.5.6.1. Key market trends, growth factors and opportunities
- 7.3.5.6.2. Market size and forecast, by Product
- 7.3.5.6.3. Market size and forecast, by Application
- 7.3.5.6.4. Market size and forecast, by End user
- 7.4. Asia-Pacific
- 7.4.1. Key trends and opportunities
- 7.4.2. Market size and forecast, by Product
- 7.4.3. Market size and forecast, by Application
- 7.4.4. Market size and forecast, by End user
- 7.4.5. Market size and forecast, by country
- 7.4.5.1. Japan
- 7.4.5.1.1. Key market trends, growth factors and opportunities
- 7.4.5.1.2. Market size and forecast, by Product
- 7.4.5.1.3. Market size and forecast, by Application
- 7.4.5.1.4. Market size and forecast, by End user
- 7.4.5.2. China
- 7.4.5.2.1. Key market trends, growth factors and opportunities
- 7.4.5.2.2. Market size and forecast, by Product
- 7.4.5.2.3. Market size and forecast, by Application
- 7.4.5.2.4. Market size and forecast, by End user
- 7.4.5.3. India
- 7.4.5.3.1. Key market trends, growth factors and opportunities
- 7.4.5.3.2. Market size and forecast, by Product
- 7.4.5.3.3. Market size and forecast, by Application
- 7.4.5.3.4. Market size and forecast, by End user
- 7.4.5.4. Australia
- 7.4.5.4.1. Key market trends, growth factors and opportunities
- 7.4.5.4.2. Market size and forecast, by Product
- 7.4.5.4.3. Market size and forecast, by Application
- 7.4.5.4.4. Market size and forecast, by End user
- 7.4.5.5. South Korea
- 7.4.5.5.1. Key market trends, growth factors and opportunities
- 7.4.5.5.2. Market size and forecast, by Product
- 7.4.5.5.3. Market size and forecast, by Application
- 7.4.5.5.4. Market size and forecast, by End user
- 7.4.5.6. Rest of Asia-Pacific
- 7.4.5.6.1. Key market trends, growth factors and opportunities
- 7.4.5.6.2. Market size and forecast, by Product
- 7.4.5.6.3. Market size and forecast, by Application
- 7.4.5.6.4. Market size and forecast, by End user
- 7.5. LAMEA
- 7.5.1. Key trends and opportunities
- 7.5.2. Market size and forecast, by Product
- 7.5.3. Market size and forecast, by Application
- 7.5.4. Market size and forecast, by End user
- 7.5.5. Market size and forecast, by country
- 7.5.5.1. Latin America
- 7.5.5.1.1. Key market trends, growth factors and opportunities
- 7.5.5.1.2. Market size and forecast, by Product
- 7.5.5.1.3. Market size and forecast, by Application
- 7.5.5.1.4. Market size and forecast, by End user
- 7.5.5.2. Middle East And Africa
- 7.5.5.2.1. Key market trends, growth factors and opportunities
- 7.5.5.2.2. Market size and forecast, by Product
- 7.5.5.2.3. Market size and forecast, by Application
- 7.5.5.2.4. Market size and forecast, by End user
- CHAPTER 8: COMPETITIVE LANDSCAPE
- 8.1. Introduction
- 8.2. Top winning strategies
- 8.3. Product Mapping of Top 10 Player
- 8.4. Competitive Dashboard
- 8.5. Competitive Heatmap
- 8.6. Top player positioning, 2022
- CHAPTER 9: COMPANY PROFILES
- 9.1. electroCore, Inc.
- 9.1.1. Company overview
- 9.1.2. Key Executives
- 9.1.3. Company snapshot
- 9.1.4. Operating business segments
- 9.1.5. Product portfolio
- 9.1.6. Business performance
- 9.1.7. Key strategic moves and developments
- 9.2. LivaNova PLC
- 9.2.1. Company overview
- 9.2.2. Key Executives
- 9.2.3. Company snapshot
- 9.2.4. Operating business segments
- 9.2.5. Product portfolio
- 9.2.6. Business performance
- 9.2.7. Key strategic moves and developments
- 9.3. MicroTransponder Inc.
- 9.3.1. Company overview
- 9.3.2. Key Executives
- 9.3.3. Company snapshot
- 9.3.4. Operating business segments
- 9.3.5. Product portfolio
- 9.4. Neuropix Company Ltd.
- 9.4.1. Company overview
- 9.4.2. Key Executives
- 9.4.3. Company snapshot
- 9.4.4. Operating business segments
- 9.4.5. Product portfolio
- 9.5. Parasym Ltd
- 9.5.1. Company overview
- 9.5.2. Key Executives
- 9.5.3. Company snapshot
- 9.5.4. Operating business segments
- 9.5.5. Product portfolio
- 9.6. Soterix Medical Inc.
- 9.6.1. Company overview
- 9.6.2. Key Executives
- 9.6.3. Company snapshot
- 9.6.4. Operating business segments
- 9.6.5. Product portfolio
- 9.7. tVNS Health GmbH
- 9.7.1. Company overview
- 9.7.2. Key Executives
- 9.7.3. Company snapshot
- 9.7.4. Operating business segments
- 9.7.5. Product portfolio
- 9.8. Beijing PINS Medical Co., Ltd
- 9.8.1. Company overview
- 9.8.2. Key Executives
- 9.8.3. Company snapshot
- 9.8.4. Operating business segments
- 9.8.5. Product portfolio
- 9.9. SetPoint Medical Corporation
- 9.9.1. Company overview
- 9.9.2. Key Executives
- 9.9.3. Company snapshot
- 9.9.4. Operating business segments
- 9.9.5. Product portfolio
- LIST OF TABLES
- TABLE 01. GLOBAL VAGUS NERVE STIMULATION MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 02. VAGUS NERVE STIMULATION MARKET FOR IMPLANTABLE VNS DEVICES, BY REGION, 2022-2032 ($MILLION)
- TABLE 03. VAGUS NERVE STIMULATION MARKET FOR EXTERNAL VNS DEVICES, BY REGION, 2022-2032 ($MILLION)
- TABLE 04. GLOBAL VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 05. VAGUS NERVE STIMULATION MARKET FOR EPILEPSY, BY REGION, 2022-2032 ($MILLION)
- TABLE 06. VAGUS NERVE STIMULATION MARKET FOR DEPRESSION, BY REGION, 2022-2032 ($MILLION)
- TABLE 07. VAGUS NERVE STIMULATION MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
- TABLE 08. GLOBAL VAGUS NERVE STIMULATION MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 09. VAGUS NERVE STIMULATION MARKET FOR HOSPITALS, BY REGION, 2022-2032 ($MILLION)
- TABLE 10. VAGUS NERVE STIMULATION MARKET FOR NEUROLOGY CLINICS, BY REGION, 2022-2032 ($MILLION)
- TABLE 11. VAGUS NERVE STIMULATION MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
- TABLE 12. VAGUS NERVE STIMULATION MARKET, BY REGION, 2022-2032 ($MILLION)
- TABLE 13. NORTH AMERICA VAGUS NERVE STIMULATION MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 14. NORTH AMERICA VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 15. NORTH AMERICA VAGUS NERVE STIMULATION MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 16. NORTH AMERICA VAGUS NERVE STIMULATION MARKET, BY COUNTRY, 2022-2032 ($MILLION)
- TABLE 17. U.S. VAGUS NERVE STIMULATION MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 18. U.S. VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 19. U.S. VAGUS NERVE STIMULATION MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 20. CANADA VAGUS NERVE STIMULATION MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 21. CANADA VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 22. CANADA VAGUS NERVE STIMULATION MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 23. MEXICO VAGUS NERVE STIMULATION MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 24. MEXICO VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 25. MEXICO VAGUS NERVE STIMULATION MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 26. EUROPE VAGUS NERVE STIMULATION MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 27. EUROPE VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 28. EUROPE VAGUS NERVE STIMULATION MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 29. EUROPE VAGUS NERVE STIMULATION MARKET, BY COUNTRY, 2022-2032 ($MILLION)
- TABLE 30. GERMANY VAGUS NERVE STIMULATION MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 31. GERMANY VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 32. GERMANY VAGUS NERVE STIMULATION MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 33. FRANCE VAGUS NERVE STIMULATION MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 34. FRANCE VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 35. FRANCE VAGUS NERVE STIMULATION MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 36. UK VAGUS NERVE STIMULATION MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 37. UK VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 38. UK VAGUS NERVE STIMULATION MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 39. ITALY VAGUS NERVE STIMULATION MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 40. ITALY VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 41. ITALY VAGUS NERVE STIMULATION MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 42. SPAIN VAGUS NERVE STIMULATION MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 43. SPAIN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 44. SPAIN VAGUS NERVE STIMULATION MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 45. REST OF EUROPE VAGUS NERVE STIMULATION MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 46. REST OF EUROPE VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 47. REST OF EUROPE VAGUS NERVE STIMULATION MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 48. ASIA-PACIFIC VAGUS NERVE STIMULATION MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 49. ASIA-PACIFIC VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 50. ASIA-PACIFIC VAGUS NERVE STIMULATION MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 51. ASIA-PACIFIC VAGUS NERVE STIMULATION MARKET, BY COUNTRY, 2022-2032 ($MILLION)
- TABLE 52. JAPAN VAGUS NERVE STIMULATION MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 53. JAPAN VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 54. JAPAN VAGUS NERVE STIMULATION MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 55. CHINA VAGUS NERVE STIMULATION MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 56. CHINA VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 57. CHINA VAGUS NERVE STIMULATION MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 58. INDIA VAGUS NERVE STIMULATION MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 59. INDIA VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 60. INDIA VAGUS NERVE STIMULATION MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 61. AUSTRALIA VAGUS NERVE STIMULATION MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 62. AUSTRALIA VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 63. AUSTRALIA VAGUS NERVE STIMULATION MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 64. SOUTH KOREA VAGUS NERVE STIMULATION MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 65. SOUTH KOREA VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 66. SOUTH KOREA VAGUS NERVE STIMULATION MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 67. REST OF ASIA-PACIFIC VAGUS NERVE STIMULATION MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 68. REST OF ASIA-PACIFIC VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 69. REST OF ASIA-PACIFIC VAGUS NERVE STIMULATION MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 70. LAMEA VAGUS NERVE STIMULATION MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 71. LAMEA VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 72. LAMEA VAGUS NERVE STIMULATION MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 73. LAMEA VAGUS NERVE STIMULATION MARKET, BY COUNTRY, 2022-2032 ($MILLION)
- TABLE 74. LATIN AMERICA VAGUS NERVE STIMULATION MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 75. LATIN AMERICA VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 76. LATIN AMERICA VAGUS NERVE STIMULATION MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 77. MIDDLE EAST AND AFRICA VAGUS NERVE STIMULATION MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 78. MIDDLE EAST AND AFRICA VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 79. MIDDLE EAST AND AFRICA VAGUS NERVE STIMULATION MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 80. ELECTROCORE, INC.: KEY EXECUTIVES
- TABLE 81. ELECTROCORE, INC.: COMPANY SNAPSHOT
- TABLE 82. ELECTROCORE, INC.: PRODUCT SEGMENTS
- TABLE 83. ELECTROCORE, INC.: PRODUCT PORTFOLIO
- TABLE 84. ELECTROCORE, INC.: KEY STRATERGIES
- TABLE 85. LIVANOVA PLC: KEY EXECUTIVES
- TABLE 86. LIVANOVA PLC: COMPANY SNAPSHOT
- TABLE 87. LIVANOVA PLC: PRODUCT SEGMENTS
- TABLE 88. LIVANOVA PLC: PRODUCT PORTFOLIO
- TABLE 89. LIVANOVA PLC: KEY STRATERGIES
- TABLE 90. MICROTRANSPONDER INC.: KEY EXECUTIVES
- TABLE 91. MICROTRANSPONDER INC.: COMPANY SNAPSHOT
- TABLE 92. MICROTRANSPONDER INC.: PRODUCT SEGMENTS
- TABLE 93. MICROTRANSPONDER INC.: PRODUCT PORTFOLIO
- TABLE 94. NEUROPIX COMPANY LTD.: KEY EXECUTIVES
- TABLE 95. NEUROPIX COMPANY LTD.: COMPANY SNAPSHOT
- TABLE 96. NEUROPIX COMPANY LTD.: PRODUCT SEGMENTS
- TABLE 97. NEUROPIX COMPANY LTD.: PRODUCT PORTFOLIO
- TABLE 98. PARASYM LTD: KEY EXECUTIVES
- TABLE 99. PARASYM LTD: COMPANY SNAPSHOT
- TABLE 100. PARASYM LTD: PRODUCT SEGMENTS
- TABLE 101. PARASYM LTD: PRODUCT PORTFOLIO
- TABLE 102. SOTERIX MEDICAL INC.: KEY EXECUTIVES
- TABLE 103. SOTERIX MEDICAL INC.: COMPANY SNAPSHOT
- TABLE 104. SOTERIX MEDICAL INC.: PRODUCT SEGMENTS
- TABLE 105. SOTERIX MEDICAL INC.: PRODUCT PORTFOLIO
- TABLE 106. TVNS HEALTH GMBH: KEY EXECUTIVES
- TABLE 107. TVNS HEALTH GMBH: COMPANY SNAPSHOT
- TABLE 108. TVNS HEALTH GMBH: PRODUCT SEGMENTS
- TABLE 109. TVNS HEALTH GMBH: PRODUCT PORTFOLIO
- TABLE 110. BEIJING PINS MEDICAL CO., LTD: KEY EXECUTIVES
- TABLE 111. BEIJING PINS MEDICAL CO., LTD: COMPANY SNAPSHOT
- TABLE 112. BEIJING PINS MEDICAL CO., LTD: PRODUCT SEGMENTS
- TABLE 113. BEIJING PINS MEDICAL CO., LTD: PRODUCT PORTFOLIO
- TABLE 114. SETPOINT MEDICAL CORPORATION: KEY EXECUTIVES
- TABLE 115. SETPOINT MEDICAL CORPORATION: COMPANY SNAPSHOT
- TABLE 116. SETPOINT MEDICAL CORPORATION: PRODUCT SEGMENTS
- TABLE 117. SETPOINT MEDICAL CORPORATION: PRODUCT PORTFOLIO
- LIST OF FIGURES
- FIGURE 01. VAGUS NERVE STIMULATION MARKET, 2022-2032
- FIGURE 02. SEGMENTATION OF VAGUS NERVE STIMULATION MARKET, 2022-2032
- FIGURE 03. TOP INVESTMENT POCKETS IN VAGUS NERVE STIMULATION MARKET (2023-2032)
- FIGURE 04. MODERATE BARGAINING POWER OF SUPPLIERS
- FIGURE 05. MODERATE BARGAINING POWER OF BUYERS
- FIGURE 06. MODERATE THREAT OF SUBSTITUTES
- FIGURE 07. MODERATE THREAT OF NEW ENTRANTS
- FIGURE 08. MODERATE INTENSITY OF RIVALRY
- FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALVAGUS NERVE STIMULATION MARKET
- FIGURE 10. VAGUS NERVE STIMULATION MARKET, BY PRODUCT, 2022(%)
- FIGURE 11. COMPARATIVE SHARE ANALYSIS OF VAGUS NERVE STIMULATION MARKET FOR IMPLANTABLE VNS DEVICES, BY COUNTRY 2022 AND 2032(%)
- FIGURE 12. COMPARATIVE SHARE ANALYSIS OF VAGUS NERVE STIMULATION MARKET FOR EXTERNAL VNS DEVICES, BY COUNTRY 2022 AND 2032(%)
- FIGURE 13. VAGUS NERVE STIMULATION MARKET, BY APPLICATION, 2022(%)
- FIGURE 14. COMPARATIVE SHARE ANALYSIS OF VAGUS NERVE STIMULATION MARKET FOR EPILEPSY, BY COUNTRY 2022 AND 2032(%)
- FIGURE 15. COMPARATIVE SHARE ANALYSIS OF VAGUS NERVE STIMULATION MARKET FOR DEPRESSION, BY COUNTRY 2022 AND 2032(%)
- FIGURE 16. COMPARATIVE SHARE ANALYSIS OF VAGUS NERVE STIMULATION MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
- FIGURE 17. VAGUS NERVE STIMULATION MARKET, BY END USER, 2022(%)
- FIGURE 18. COMPARATIVE SHARE ANALYSIS OF VAGUS NERVE STIMULATION MARKET FOR HOSPITALS, BY COUNTRY 2022 AND 2032(%)
- FIGURE 19. COMPARATIVE SHARE ANALYSIS OF VAGUS NERVE STIMULATION MARKET FOR NEUROLOGY CLINICS, BY COUNTRY 2022 AND 2032(%)
- FIGURE 20. COMPARATIVE SHARE ANALYSIS OF VAGUS NERVE STIMULATION MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
- FIGURE 21. VAGUS NERVE STIMULATION MARKET BY REGION, 2022
- FIGURE 22. U.S. VAGUS NERVE STIMULATION MARKET, 2022-2032 ($MILLION)
- FIGURE 23. CANADA VAGUS NERVE STIMULATION MARKET, 2022-2032 ($MILLION)
- FIGURE 24. MEXICO VAGUS NERVE STIMULATION MARKET, 2022-2032 ($MILLION)
- FIGURE 25. GERMANY VAGUS NERVE STIMULATION MARKET, 2022-2032 ($MILLION)
- FIGURE 26. FRANCE VAGUS NERVE STIMULATION MARKET, 2022-2032 ($MILLION)
- FIGURE 27. UK VAGUS NERVE STIMULATION MARKET, 2022-2032 ($MILLION)
- FIGURE 28. ITALY VAGUS NERVE STIMULATION MARKET, 2022-2032 ($MILLION)
- FIGURE 29. SPAIN VAGUS NERVE STIMULATION MARKET, 2022-2032 ($MILLION)
- FIGURE 30. REST OF EUROPE VAGUS NERVE STIMULATION MARKET, 2022-2032 ($MILLION)
- FIGURE 31. JAPAN VAGUS NERVE STIMULATION MARKET, 2022-2032 ($MILLION)
- FIGURE 32. CHINA VAGUS NERVE STIMULATION MARKET, 2022-2032 ($MILLION)
- FIGURE 33. INDIA VAGUS NERVE STIMULATION MARKET, 2022-2032 ($MILLION)
- FIGURE 34. AUSTRALIA VAGUS NERVE STIMULATION MARKET, 2022-2032 ($MILLION)
- FIGURE 35. SOUTH KOREA VAGUS NERVE STIMULATION MARKET, 2022-2032 ($MILLION)
- FIGURE 36. REST OF ASIA-PACIFIC VAGUS NERVE STIMULATION MARKET, 2022-2032 ($MILLION)
- FIGURE 37. LATIN AMERICA VAGUS NERVE STIMULATION MARKET, 2022-2032 ($MILLION)
- FIGURE 38. MIDDLE EAST AND AFRICA VAGUS NERVE STIMULATION MARKET, 2022-2032 ($MILLION)
- FIGURE 39. TOP WINNING STRATEGIES, BY YEAR
- FIGURE 40. TOP WINNING STRATEGIES, BY DEVELOPMENT
- FIGURE 41. TOP WINNING STRATEGIES, BY COMPANY
- FIGURE 42. PRODUCT MAPPING OF TOP 10 PLAYERS
- FIGURE 43. COMPETITIVE DASHBOARD
- FIGURE 44. COMPETITIVE HEATMAP: VAGUS NERVE STIMULATION MARKET
- FIGURE 45. TOP PLAYER POSITIONING, 2022
- FIGURE 46. ELECTROCORE, INC.: NET SALES, 2020-2022 ($MILLION)
- FIGURE 47. ELECTROCORE, INC.: REVENUE SHARE BY REGION, 2022 (%)
- FIGURE 48. LIVANOVA PLC: NET REVENUE, 2019-2021 ($MILLION)
- FIGURE 49. LIVANOVA PLC: REVENUE SHARE BY SEGMENT, 2021 (%)
- FIGURE 50. LIVANOVA PLC: REVENUE SHARE BY REGION, 2021 (%)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook